Cardiac Imaging

What Is the Best Initial Imaging for TAVR Aortic and Vascular Access Planning?

·
What Is the Best Initial Imaging for TAVR Aortic and Vascular Access Planning?

An 82-year-old patient with severe, symptomatic aortic stenosis has been evaluated by the multidisciplinary heart team. Given his comorbidities, he is considered a high-risk candidate for surgical aortic valve replacement, and the team has recommended transcatheter aortic valve replacement (TAVR). As the referring physician or consulting cardiologist, your next step is to map the entire vascular route to ensure the delivery system can safely reach the heart. This requires a detailed assessment of the aorta from the arch down to the femoral arteries. The central imaging question is: which initial study provides the comprehensive, high-resolution roadmap needed for this critical preprocedural planning?

For this specific clinical scenario—assessing the supravalvular aorta and vascular access for TAVR—the American College of Radiology (ACR) Appropriateness Criteria rate a comprehensive CTA chest abdomen pelvis with IV contrast as Usually appropriate. This article details the clinical workflow, rationale, and downstream decisions based on this recommendation.

Who Fits This Clinical Scenario for TAVR Preprocedural Planning?

This guidance applies specifically to patients who have been identified as candidates for TAVR and require initial, comprehensive imaging to plan the procedural approach. The primary goal of the imaging study is to evaluate the feasibility of the default and preferred access route—the transfemoral approach—which necessitates a complete anatomical survey from the aortic arch to the common femoral arteries.

Inclusion criteria for this workflow:

  • Patients with a confirmed diagnosis of severe aortic stenosis.
  • Patients who have been deemed suitable for TAVR by a heart team.
  • The clinical question is the initial assessment of the supravalvular aorta (arch, descending thoracic aorta) and the iliofemoral vascular access pathway.

This workflow may not apply if:

  • The primary question is aortic root assessment: If the focus is solely on measuring the aortic annulus, sinus of Valsalva, and coronary heights for valve sizing, that constitutes a related but distinct scenario. While often acquired during the same scan, the protocol and analysis priorities differ.
  • The patient has a known contraindication to CTA: Patients with severe chronic kidney disease (e.g., eGFR < 30 mL/min/1.73 m²) or a history of severe anaphylactic reaction to iodinated contrast may require an alternative initial study, such as magnetic resonance angiography (MRA).
  • A non-femoral approach is already planned: If a transfemoral approach has already been ruled out based on prior imaging or severe known peripheral artery disease, the imaging plan may focus specifically on alternative access sites like the subclavian, axillary, or carotid arteries.

What Anatomic and Pathologic Features Are You Assessing?

The pre-TAVR planning scan is not a search for a single diagnosis but a meticulous anatomical survey to identify any feature that could complicate or prevent the safe passage of the large-bore TAVR delivery system. The key objectives are to measure vessel dimensions and characterize potential hazards along the entire route.

Iliofemoral Artery Caliber, Calcification, and Tortuosity: This is the most critical assessment for a transfemoral approach. The scan must provide precise measurements of the minimum luminal diameter of the common and external iliac arteries and the common femoral arteries. Severe, circumferential calcification can make the vessel wall rigid and prone to dissection or rupture, while extreme tortuosity can prevent the sheath from advancing.

Atherosclerotic Plaque Burden: The scan evaluates the thoracic and abdominal aorta for significant atherosclerotic disease. Large, mobile, or ulcerated plaques, particularly in the aortic arch, represent a high risk for embolic stroke during catheter manipulation. Identifying this allows the proceduralist to plan a technique that minimizes contact with these high-risk areas.

Aortic Aneurysm and Dissection: The presence of a significant thoracic or abdominal aortic aneurysm can influence the procedure and may need to be addressed. The scan also rules out underlying aortic dissection, which would be a contraindication to the standard TAVR procedure.

Alternative Access Routes: A comprehensive CTA also provides a clear view of potential alternative access sites, such as the subclavian and axillary arteries. If the iliofemoral route is deemed unsuitable, these vessels can be measured and assessed on the same dataset without requiring additional imaging.

Why Is a Comprehensive CTA the Recommended Study for TAVR Access Planning?

The ACR rates CTA chest abdomen pelvis with IV contrast as Usually appropriate because it provides a complete, high-resolution, three-dimensional dataset that addresses all the critical planning questions in a single, rapid acquisition.

The primary strength of CTA is its exceptional spatial resolution and ability to visualize calcium. This allows for sub-millimeter-accurate measurements of vessel lumens, which is essential for determining if the delivery sheath will fit. Advanced post-processing software uses this CTA data to create a “centerline” reconstruction, automatically measuring the minimum diameter along the entire iliofemoral path and straightening tortuous vessels for accurate length assessment.

Comparison to Other Modalities:

  • MRA chest abdomen pelvis with IV contrast: Rated May be appropriate, this is the best alternative for patients who cannot receive iodinated contrast. MRA avoids ionizing radiation and is excellent at visualizing non-calcified plaque. However, it is generally considered less accurate than CTA for measuring heavily calcified vessels, as severe calcification creates signal voids that can obscure the true lumen. MRA scans are also longer and more susceptible to motion artifacts.
  • Catheter Aortography: Rated Usually not appropriate for initial planning. While it is the historical gold standard for luminal imaging, conventional angiography is invasive and provides only a two-dimensional projection of the vessel lumen. It cannot visualize the vessel wall, plaque thickness, or extra-luminal structures. Its role is now primarily intraprocedural, not for preprocedural planning.
  • US duplex Doppler chest abdomen pelvis: Rated Usually not appropriate. Ultrasound is excellent for focal vessel assessment but is not practical or reliable for mapping the entire, deep-seated pathway from the chest to the pelvis. Bowel gas and body habitus limit its utility for a comprehensive aortic and iliac evaluation.

The radiation dose for a comprehensive TAVR planning CTA is significant (ACR Relative Radiation Level ☢☢☢☢☢, 30-100 mSv), but it is justified by the critical importance of the data for ensuring the safety and success of a major cardiac intervention. The procedural risks associated with improper planning (e.g., vessel rupture, stroke) far outweigh the stochastic risk from this one-time diagnostic scan.

Once you’ve decided on a comprehensive CTA, our protocol guide covers the technique, contrast, and reading principles: CT Chest/Abdomen/Pelvis with IV Contrast.

What Happens After the TAVR Planning CTA?

The results of the CTA are typically analyzed by both a radiologist and the structural heart team, often using specialized software. The findings directly guide the procedural plan and lead to one of three primary pathways.

  • “Go” for Transfemoral Access: If the CTA confirms that the iliofemoral arteries have a sufficient minimum luminal diameter (e.g., >5.5 mm, depending on the specific TAVR system), with no prohibitive calcification, tortuosity, or stenosis, the patient is cleared for a standard transfemoral TAVR. This is the most common and least invasive approach.
  • “No-Go” for Transfemoral Access: If the CTA reveals a “hostile” iliofemoral system—such as minimum diameters smaller than the required sheath size, severe circumferential calcification creating an un-expandable “rock pipe,” or extreme tortuosity—the transfemoral route is abandoned. The team then uses the same CTA dataset to evaluate alternative access sites (e.g., subclavian, axillary, transcaval, transcarotid) to determine the next best option.
  • Borderline or Indeterminate Findings: In cases where vessel size is borderline or there is moderate, non-prohibitive disease, the team may plan for adjunctive techniques. This could include performing balloon angioplasty of a mild iliac stenosis just before sheath insertion or having covered stents available in case of a vascular complication. The CTA provides the forewarning needed to prepare for these possibilities.

Common Pitfalls in TAVR Access Imaging and When to Escalate

Accurate TAVR planning imaging is crucial, and several pitfalls can compromise the quality of the study and the safety of the procedure.

  • Suboptimal Contrast Timing: An improperly timed contrast bolus can result in poor arterial opacification or significant venous contamination, making accurate luminal measurements impossible. This often requires a repeat scan.
  • Ignoring the Access Site: Failing to scan all the way to the femoral heads can miss critical disease at the common femoral artery puncture site. The scan protocol must include the entire vessel from origin to potential entry point.
  • Relying on 2D Measurements: Measuring vessel diameters on simple axial or coronal images is inaccurate, especially in tortuous vessels. Analysis must be performed using multiplanar reformats (MPR) or dedicated centerline software to find the true minimum luminal diameter perpendicular to the vessel’s path.

If the CTA reveals anatomy that is prohibitive for all standard percutaneous access routes (femoral, subclavian, etc.), the case should be escalated for discussion with the entire heart team, including cardiac surgeons, to consider transapical or direct aortic access, or to re-evaluate the patient for open surgical valve replacement.

Related ACR Topics and Tools

This article covers a single, focused scenario. For a broader view of all clinical variants within this topic, or to explore the technical details of the recommended study, the following resources are available.

Frequently Asked Questions

Why is a single CTA of the chest, abdomen, and pelvis necessary instead of just a pelvic CTA?

A comprehensive CTA is required because TAVR planning involves assessing the entire path the delivery system will travel. This includes evaluating the aortic arch for mobile plaque (a stroke risk), the descending aorta for tortuosity and aneurysms, and the iliac arteries for size and disease, before finally assessing the femoral access site. A pelvic-only CTA would miss critical information in the chest and abdomen.

What is the minimum iliofemoral artery diameter required for a transfemoral TAVR?

The minimum required diameter depends on the specific TAVR device and delivery system being used. Sheath sizes vary, but a general rule of thumb is that a minimum luminal diameter of 5.5 mm to 6.0 mm is often required for the current generation of devices. The final decision is made by the heart team based on the specific device’s instructions for use and the patient’s anatomy.

Can a patient with an eGFR of 25 mL/min/1.73 m² still get a TAVR planning CTA?

A patient with severe chronic kidney disease (e.g., eGFR < 30) is at high risk for contrast-induced nephropathy. In this situation, the heart team must weigh the risks and benefits. Options include aggressive pre- and post-procedure hydration, using a minimal-contrast protocol, or opting for an alternative imaging modality like MRA without gadolinium or a non-contrast CT combined with intravascular ultrasound (IVUS). The decision is highly individualized.

Does the TAVR planning CTA also provide the information needed for valve sizing?

Yes, in most centers, a single, ECG-gated CTA acquisition is performed that provides all necessary information. The ECG-gating is focused on the aortic root to obtain motion-free images for precise annular measurements, while the rest of the scan from the arch to the femorals is typically non-gated. This single, comprehensive protocol allows for both valve sizing and access route planning.

What if the CTA shows an incidental finding, like a small renal mass?

Incidental findings are common on comprehensive CTAs. The radiologist will characterize the finding according to standard systems (e.g., Bosniak classification for renal cysts). The heart team, in consultation with the patient’s primary physician, will determine the urgency of a workup. In most cases, a potentially life-saving TAVR procedure for severe aortic stenosis will take precedence over the workup of a small, likely benign incidentaloma.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026